We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.23B
AUM Growth
+$250M
Cap. Flow
-$112M
Cap. Flow %
-2.15%
Top 10 Hldgs %
28.91%
Holding
145
New
10
Increased
12
Reduced
104
Closed
6

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$55.9M
2
WST icon
West Pharmaceutical
WST
+$47M
3
ALRM icon
Alarm.com
ALRM
+$45.3M
4
GLOB icon
Globant
GLOB
+$38.4M
5
ADI icon
Analog Devices
ADI
+$24.6M

Top Sells

Rank Stock Value
1
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$70.1M
2
CGNX icon
Cognex
CGNX
+$62.5M
3
SRCL
Stericycle Inc
SRCL
+$42.1M
4
VEEV icon
Veeva Systems
VEEV
+$25.1M
5
NEOG icon
Neogen
NEOG
+$24.7M

Sector Composition

Rank Sector Weight
1 Technology 26.74%
2 Industrials 21.8%
3 Healthcare 18.73%
4 Consumer Discretionary 10.85%
5 Consumer Staples 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
101
Procter & Gamble
PG
$336B
$2.06M 0.04%
23,677
-748
-3% -$65.9K
CAH icon
102
Cardinal Health
CAH
$53.9B
$1.55M 0.03%
19,873
-473
-2% -$35.7K
TGT icon
103
Target
TGT
$65.6B
$1.31M 0.03%
25,134
-25,778
-51% -$1.41M
IVV icon
104
iShares Core S&P 500 ETF
IVV
$878B
$1.1M 0.02%
4,510
+1,234
+38% +$298K
WOLF icon
105
Wolfspeed
WOLF
$1.23B
$1.06M 0.02%
43,077
-9,874
-19% -$236K
SRCL
106
DELISTED
Stericycle Inc
SRCL
$992K 0.02%
13,004
-511,897
-98% -$42.1M
JPM icon
107
JPMorgan Chase
JPM
$935B
$967K 0.02%
10,575
– –
IWM icon
108
iShares Russell 2000 ETF
IWM
$79.8B
$859K 0.02%
6,097
-4,836
-44% -$669K
QCOM icon
109
Qualcomm
QCOM
$155B
$764K 0.01%
13,828
-322,096
-96% -$18M
RPG icon
110
Invesco S&P 500 Pure Growth ETF
RPG
$2.01B
$659K 0.01%
34,980
– –
WFM
111
DELISTED
Whole Foods Market Inc
WFM
$562K 0.01%
13,353
-351,682
-96% -$12.8M
IWF icon
112
iShares Russell 1000 Growth ETF
IWF
$121B
$561K 0.01%
18,852
– –
IWB icon
113
iShares Russell 1000 ETF
IWB
$48.2B
$536K 0.01%
3,961
-251
-6% -$33.5K
CNO icon
114
CNO Financial Group
CNO
$5.14B
$482K 0.01%
+23,094
New +$477K
WFC icon
115
Wells Fargo
WFC
$261B
$381K 0.01%
6,881
– –
PCAR icon
116
PACCAR
PCAR
$69.8B
$379K 0.01%
8,615
– –
HRL icon
117
Hormel Foods
HRL
$13.8B
$335K 0.01%
9,808
+3,953
+68% +$136K
ABCO
118
DELISTED
Advisory Board Co
ABCO
$319K 0.01%
6,190
-517
-8% -$25.9K
IWO icon
119
iShares Russell 2000 Growth ETF
IWO
$14.3B
$299K 0.01%
1,769
-1,917
-52% -$316K
ROP icon
120
Roper Technologies
ROP
$38.8B
$286K 0.01%
1,234
-280
-18% -$62K
BRK.B icon
121
Berkshire Hathaway Class B
BRK.B
$1.1T
$279K 0.01%
1,645
– –
IUSG icon
122
iShares Core S&P US Growth ETF
IUSG
$31.7B
$273K 0.01%
+5,657
New +$270K
IWR icon
123
iShares Russell Mid-Cap ETF
IWR
$56B
$269K 0.01%
5,592
-1,072
-16% -$50.8K
SYK icon
124
Stryker
SYK
$125B
$264K 0.01%
1,900
– –
KO icon
125
Coca-Cola
KO
$377B
$260K 0.01%
5,786
– –
2 3 4
5
6

Similar funds

BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
U
Uber San Francisco, California $3.6B AUM 19.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Riverbridge Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Riverbridge Partners held 145 positions worth $5.23B, up 5% from $4.98B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Riverbridge Partners's Q2 2017 filing shows 10 new, 12 increased, 104 reduced and 6 closed positions. Its largest new stake was Evolent Health: 2,322,594 shares worth $58.9M. The largest sale was ZELTIQ Aesthetics, Inc., an estimated $70.1M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

  • Riverbridge Partners's largest Q2 2017 buy was Evolent Health: 2,322,594 shares worth $58.9M.
  • Riverbridge Partners added most to Verisk Analytics in Q2 2017, an estimated $23.2M increase.
  • Riverbridge Partners's biggest Q2 2017 reduction was Cognex, cutting an estimated $62.5M.
  • Riverbridge Partners fully exited ZELTIQ Aesthetics, Inc. in Q2 2017, selling an estimated $70.1M.
  • Riverbridge Partners's ten largest holdings make up 29% of its $5.23B portfolio in Q2 2017.
  • Riverbridge Partners opened 10 new positions and closed 6 in Q2 2017.
  • Riverbridge Partners's portfolio value rose 5% quarter-over-quarter to $5.23B.

Based on Riverbridge Partners's 13F filing for Q2 2017, filed 24 Jul 2017.